CAR T cells are a powerful immunotherapy, currently used in cancer treatments, in which a patient’s own immune T cells are engineered to express Chimeric Antigen Receptors (CARs). These CARs re-program the T cells to recognize and eliminate specific diseased or infected cells, such as cancer cells or, potentially, HIV-infected cells.
Read the Full Article from TechnolgyNetworks